• SENSEX 81,028.02
    1,718.01 (+2.17%)
  • BANKNIFTY 57,773.65
    1,860.05 (+3.33%)
  • Billionbrains
    208.75 112.02(%)
  • Lenskart Solut.
    733.10 767.40(%)
  • NSE
    1,953.95 1,900.00(%)
  • Cartrade Tech
    2,712.90 3,291.35(%)
  • Apar Inds.
    13,783.50 6,800.00(%)
  • Tonbo Imaging
    1,427.75 1,013.95(%)
  • M & M
    3,295.00 3,840.00(%)
  • Cummins India
    3,903.00 3,883.30(%)
  • HDFC Bank
    787.00 1,017.90(%)
  • ICICI Bank
    1,569.30 1,501.45(%)
  • Sai Life
    1,815.55 1,697.00(%)
  • Hitachi Energy
    26,720.00 16,104.00(%)
  • Avenue Super.
    3,408.40 3,104.00(%)
  • Axis Bank
    1,323.90 1,418.30(%)
  • Bharti Airtel
    2,120.00 2,174.70(%)
  • Larsen & Toubro
    4,118.90 4,440.00(%)
  • Jio Platforms
    1,390.00 1,356.40(%)
  • CG Power & Ind
    734.00 525.50(%)
  • Reliance Industries
    1,318.10 1,611.20(%)
  • SBI
    1,020.00 1,234.80(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Windlas Biotech Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 36133.0
  • ISIN : INE0H5O01029
921.25 48 (5.47%)
  • As on 06 Nov 2026 (EOD)

  • Today’s Low

    876.00

  • Today’s High

    930.00

  • Open

    890.00

  • Perv Close

    873.45

  • 52W Low

    697.40

  • 52W High

    1,181.90

Key Indicators

  • P/E(TTM)

    28.68

  • Mar.Cap (₹Cr.)

    1,901.11

  • Div & Yield %

    0.68

  • Book Value(₹)

    281.35

  • Debt-Equity Ratio

    5.47

  • AGM Date

    05-Nov-2026

  • EPS

    32.19

  • P/E Ratio

    28.68

Financials Ratios

  • Debt-Equity Ratio

    0.01

  • Mar.Cap (₹Cr.)

    1,901.11

  • RONW (%)

    13.66

  • ROCE (%)

    18.07

Score Board

  • Equity (₹ in Cr.)

    10.32

  • BV (₹)

    281.30

  • Sales( ₹ in Cr.)

    904.09

  • NP (in Cr.)

    66.44

  • NP Var(%)

    10.0

  • Div%

    123.0

  • CPS (₹)

    47.10

  • EPS (₹)

    32.20

  • Traded Value (₹ in Lakhs)

    1,905.45

  • 52 Week High

    1,181.90

  • 52 Week Low

    697.40

  • Price BSE

    923.0

  • Price NSE

    921.00

  • Market Capital( in Cr.)

    1,905.45

  • P/C Ratio

    19.60

  • P/E Ratio

    28.70

  • Price Vs.BV

    32.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 904.09 759.88 630.96 513.08 465.93 427.60
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 904.09 759.88 630.96 513.08 465.93 427.60
Other Income 17.80 17.65 13.47 9.97 6.71 3.09
Stock Adjustments -7.10 21.52 -9.59 15.27 4.74 -3.67
Total Income 914.79 799.05 634.84 538.32 477.38 427.02
EXPENDITURE :            
Raw Materials 550.13 493.38 386.59 340.71 307.56 270.74
Power and Fuel Cost 28.29 21.61 16.15 12.90 11.01 11.53
Employee Cost 152.09 122.92 87.46 70.32 63.41 58.32
Other Manufacturing Expenses 9.72 11.57 10.52 8.63 8.95 8.37
Selling and Administration Expenses 45.47 33.53 35.92 30.13 23.08 15.09
Miscellaneous Expenses 6.58 4.28 6.63 5.41 3.78 37.54
Employee Benefit Expenses 152.09 122.92 87.46 70.32 63.41 58.32
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 792.29 687.29 543.27 468.10 417.78 401.60
Operating Profit 122.50 111.76 91.57 70.21 59.60 25.44
Interest 4.83 4.38 1.10 0.79 1.42 1.29
Gross Profit 117.67 107.38 90.47 69.42 58.18 24.15
Depreciation 30.74 27.99 13.44 12.36 12.15 12.97
Profit Before Tax 86.93 79.39 77.03 57.06 46.03 11.18
Current Tax 20.70 18.27 17.34 14.35 10.13 4.84
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.20 0.47 1.54 0.06 -2.66 1.33
Reported Net Profit 66.44 60.65 58.14 42.64 38.56 5.01
Extraordinary Items 0.00 0.01 0.00 0.65 0.01 -26.17
Adjusted Net Profit 66.44 60.64 58.14 41.99 38.55 31.18
Adjustment below Net Profit 0.11 -0.54 -0.24 -0.16 -0.18 -26.37
P & L Balance brought forward 274.90 226.29 176.70 141.84 103.46 124.82
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 12.16 11.50 8.32 7.63 0.00 0.00
P & L Balance carried down 329.29 274.90 226.29 176.70 141.84 103.46
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 123.00 116.00 110.00 80.00 70.00 0.00
Dividend Per Share(Rs) 6.30 5.80 5.50 4.00 3.50 0.00
Earnings Per Share-Unit Curr 31.48 28.94 27.96 20.38 17.69 7.81
Earnings Per Share(Adj)-Unit Curr 31.48 28.94 27.96 20.38 17.69 -
Book Value 275.20 241.31 216.51 192.42 181.30 310.39
Book Value(Adj)-Unit Curr 275.20 241.31 216.51 192.42 181.30 -

Shareholding Pattern

  • Promoter Group

    63.31%

  • Public Share Holding

    36.69%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 4,684,012 22.70 4,684,012 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 8,381,340 40.61 8,381,340 1
Others 0 0.00 0 0
Sub Total 13,065,352 63.31 13,065,352 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 430,121 2.08 430,121 46
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 639,716 3.10 639,716 4
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 854,428 4.14 854,428 11
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 1,924,265 9.32 1,924,265 61
2] Non Institution
Bodies Corporate 431,473 2.09 431,473 204
Clearing Members 42,736 0.21 42,736 10
Directors of their Relatives 23,533 0.11 23,533 1
Employees 46,252 0.22 46,252 120
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 264,937 1.28 264,937 876
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 234,811 1.14 234,811 1,167
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 404,138 1.96 404,138 4
Individuals holding nominal share capital up to Rs. 1 lakh 4,136,379 20.04 4,136,379 46,254
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 173 0.00 173 1
Others 32,354 0.16 32,354 1
Sub Total 5,646,612 27.36 5,646,612 48,664
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 20,636,229 100.00 20,636,229 48,732

Company Background

Windlas Biotech LtdPharmaceuticals - Indian - Formulations

  • Windlas Biotech Ltd
  • BSE Code : 36133.0
  • ISIN : INE0H5O01029

  • Incorporation Year

    2001

  • Registered Office

    40/1 Mohabewala Industrial
    Area, Dehradun,
    Uttarakhand-248110

  • Telephone

    91-135-6608000

  • FAX

  • Chairman

    Vivek Dhariwal

  • Managing Director

    MANOJ KUMAR WINDLASS

  • Company Secretary

    Ananta Narayan Panda

  • Auditor

    J C Bhalla & Co

  • Face Value

    5

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Windlas Biotech Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Windlas Biotech 923.35 921.89 904.09 28.68 15.81
Abbott India 26,592.70 7,217.19 6,929.05 35.00 43.78
Astrazeneca Phar 6,294.90 2,304.07 2,275.58 92.78 27.86
Glaxosmi. Pharma 2,500.70 3,932.76 3,790.20 37.16 58.17
Evonile Pharma 1,714.35 393.10 354.33 -1,058.24 15.94
Cipla 1,401.75 20,102.60 18,979.95 42.72 13.88
Bliss GVS Pharma 630.80 773.53 729.81 41.12 12.51
Amrutanjan Healt 518.60 520.13 502.55 26.17 24.16
Fermenta Biotec. 416.65 474.15 450.25 19.45 18.77
Guj. Themis Bio. 387.70 168.25 165.82 103.66 18.05
Ambalal Sarabhai 36.00 19.52 3.94 66.67 6.77